GlaxoSmith C H L

GLAXOSMITHKLINECONSUMERHEALTHCARE15 Apr 2020

FMCG

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in GlaxoSmith C H L

GlaxoSmith C H L

FMCG

GLAXOSMITHKLINECONSUMERHEALTHCARE15 Apr 2020

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
10-May-2019	D	The Register of Members and Share Transfer Books will remain closed from Saturday, July 27, 2019 to Friday, August 2, 2019, both days inclusive for the purpose of Dividend and Annual General Meeting. The Board also recommended a Dividend at the rate of Rs. 105/- per equity share of Rs. 10 each. The Dividend, if approved by the shareholders in the ensuing Annual General Meeting scheduled to be held on Friday, August 2, 2019, will be paid to those members whose names appear in the Company's Register of Members and to those persons whose names appear as Beneficial owners as per the details to be furnished by National Securities Depository Limited and Central Depository Services (India) Ltd. as at the close of business hours on Friday, July 26, 2019. The 60th Annual General Meeting of the members of the Company will be held on Friday, August 2, 2019 at 9.30 a.m. at Punjab Public School Auditorium, The Punjab Public School (Senior Wing), Nabha 147 201 (Punjab	25-Jul-2019
11-May-2018	D	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 11, 2018, inter alia, has recommended a Dividend at the rate of Rs. 75/- per equity share of Rs. 10 each. The dividend shall be paid to the entitled Members on or before September 07, 2018.	31-Jul-2018
11-May-2017	D	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 11, 2017, inter alia, has recommended a Dividend at the rate of Rs. 70/- per equity share of Rs. 10 each. The dividend shall be paid to the entitled Members on or before September 08, 2017.	02-Aug-2017
17-May-2016	D	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 17, 2016, inter alia, has recommended a Dividend at the rate of Rs. 70/- per equity share of Rs. 10 each. The dividend shall be paid to the entitled Members on or before September 04, 2016.	26-Jul-2016
08-May-2015	D	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 08, 2015, inter alia, has recommended a Dividend at the rate of Rs. 55/- per equity share of Rs. 10 each. The dividend shall be paid to the entitled Members on or before September 05, 2015.	27-Jul-2015
09-May-2014	D	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 09, 2014, inter alia, has recommended a Dividend at the rate of Rs. 45/- per equity share of Rs. 10 each. The dividend shall be paid to the entitled Members on or before September 05, 2014.	28-Jul-2014
15-Feb-2013	D	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 15, 2013, inter alia, has recommended a Dividend at the rate of Rs. 45 per equity share of Rs. 10 each.	19-Mar-2013
06-Feb-2012	D	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 06, 2012, inter alia, has recommended a Dividend at the rate of Rs. 35/- per equity share of Rs. 10 each.	09-Mar-2012
02-Feb-2011	D	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 02, 2011, inter alia, has recommended a Dividend at the rate of Rs. 50 per equity share of Rs. 10 each (Dividend of Rs. 25 per equity share and a Special Dividend of Rs. 25 per equity share to celebrate Golden Jubilee of the Company).	11-Mar-2011
02-Feb-2011	D	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 02, 2011, inter alia, has recommended a Dividend at the rate of Rs. 50 per equity share of Rs. 10 each (Dividend of Rs. 25 per equity share and a Special Dividend of Rs. 25 per equity share to celebrate Golden Jubilee of the Company).	11-Mar-2011
25-Jan-2010	D	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 25, 2010, inter alia, has recommended a Final Dividend at the rate of Rs. 18 per equity share of Rs. 10 each.	09-Apr-2010
27-Jan-2009	D	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 27, 2009, inter alia, has recommended a Final Dividend at the rate of Rs 5 per equity share of Rs 10 each.	13-Apr-2009
24-Oct-2008	D	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 24, 2008, inter alia, has declared an interim dividend of Rs 10/- per equity share for the year ending December 31, 2008.	29-Oct-2008
23-Oct-2007	D	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 23, 2007, inter alia, has declared an interim dividend of Rs 12.00 per equity share for the year ending December 31, 2007.	29-Oct-2007
23-Jun-2021	BC	Trading Members of the Exchange are hereby informed that the under mentioned scrip code of the Company which has been suspended due to record date fixed for Corporate Action of Amalgamation shall be	24-Jun-2021
03-Apr-2020	BC	Amalgamation	17-Apr-2020
08-Apr-2020	BC	Sub: Suspension of trading in equity shares -GlaxoSmithKline Consumer Healthcare LimitedIn pursuance of Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Pa	16-Apr-2020
13-Mar-2020	BC	Pursuant to Reg 30(7) of SEBI LODR, further to our communication dated Feb 26, 2020, plS see enclosed a copy of the order dated Feb 26, 2020 and clarification dated Feb 28, 2020 alongwith order as pe	01-Apr-2020
13-Jan-2020	BC	GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2020 ,inter alia, to consider and approve Pursuant to Regulati	06-Feb-2020

Announcement Date10-May-2019

Ex Dividend Date25-Jul-2019

Dividend(%)1050

Announcement Date11-May-2018

Ex Dividend Date31-Jul-2018

Dividend(%)750

Announcement Date11-May-2017

Ex Dividend Date02-Aug-2017

Dividend(%)700

Announcement Date17-May-2016

Ex Dividend Date26-Jul-2016

Dividend(%)700

Announcement Date08-May-2015

Ex Dividend Date27-Jul-2015

Dividend(%)550

Announcement Date09-May-2014

Ex Dividend Date28-Jul-2014

Dividend(%)450

Announcement Date15-Feb-2013

Ex Dividend Date19-Mar-2013

Dividend(%)450

Announcement Date06-Feb-2012

Ex Dividend Date09-Mar-2012

Dividend(%)350

Announcement Date02-Feb-2011

Ex Dividend Date11-Mar-2011

Dividend(%)250

Announcement Date02-Feb-2011

Ex Dividend Date11-Mar-2011

Dividend(%)250

Announcement Date25-Jan-2010

Ex Dividend Date09-Apr-2010

Dividend(%)180

Announcement Date27-Jan-2009

Ex Dividend Date13-Apr-2009

Dividend(%)50

Announcement Date24-Oct-2008

Ex Dividend Date29-Oct-2008

Dividend(%)100

Announcement Date23-Oct-2007

Ex Dividend Date29-Oct-2007

Dividend(%)120

No Rights has been declared by GLAXOSMITHKLINECONSUMERHEALTHCARE

Book Closure

Record Date	Split Date	Purpose
24-Jun-2021	-	Trading Members of the Exchange are hereby informed that the under mentioned scrip code of the Company which has been suspended due to record date fixed for Corporate Action of Amalgamation shall be
17-Apr-2020	-	Amalgamation
16-Apr-2020	-	Sub: Suspension of trading in equity shares -GlaxoSmithKline Consumer Healthcare LimitedIn pursuance of Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Pa
01-Apr-2020	-	Pursuant to Reg 30(7) of SEBI LODR, further to our communication dated Feb 26, 2020, plS see enclosed a copy of the order dated Feb 26, 2020 and clarification dated Feb 28, 2020 alongwith order as pe
06-Feb-2020	-	GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2020 ,inter alia, to consider and approve Pursuant to Regulati

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
GlaxoSmithkline Consumer Healthcare Ltd(Merged) ₹10,732.60(0.00/0.00%)	10,732.60	+0.00	45,141.32	49.00	39.13	10.87
Vadilal Industries Ltd ₹4,782.85(+80.65/1.72%)	4,782.85	+80.65	3,438.87	98.95	36.51	11.84
Hatsun Agro Product Ltd ₹1,036.60(-29.90/-2.80%)	1,036.60	-29.90	23,090.09	20.04	86.29	14.67
Dabur India Ltd ₹558.45(+27.65/5.21%)	558.45	+27.65	98,959.53	8.67	65.62	14.33
Hindustan Unilever Ltd ₹2,379.40(+123.20/5.46%)	2,379.40	+123.20	559,061.74	-5.44	54.92	10.97
Agro Tech Foods Ltd ₹726.70(+5.30/0.73%)	726.70	+5.30	1,770.97	-7.26	229.48	3.53

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18
Gross Sales	1158.86	1345.09	1194.32	1286.06	1116.82	1271.99
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1158.86	1345.09	1194.32	1286.06	1116.82	1271.99
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	116.04	78.13	126.58	122.89	124.25	89.01
Total Income	1274.90	1423.22	1320.90	1408.95	1241.07	1361.00
Total Expenditure	886.78	949.28	913.92	967.58	878.29	918.32
PBIDT	388.12	473.94	406.98	441.37	362.78	442.68
Interest	1.49	1.78	1.70	0.20	0.21	0.19
PBDT	386.63	472.16	405.28	441.17	362.57	442.49
Depreciation	19.17	20.33	19.62	14.92	15.81	15.07
Tax	89.32	74.22	135.76	139.16	123.97	150.97
Deferred Tax	1.51	32.30	1.82	1.28	1.73	0.96
Reported Profit After Tax	276.63	345.31	248.08	285.81	221.06	275.49
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	276.63	345.31	248.08	285.81	221.06	275.49

EPS (Unit Curr.)	65.77	82.10	58.98	67.95	52.56	65.50
EPS (Adj) (Unit Curr.)	65.77	82.10	58.98	67.95	52.56	65.50
Calculated EPS (Unit Curr.)	65.77	82.10	58.98	67.95	52.56	65.50
Calculated EPS (Adj) (Unit Curr.)	65.77	82.10	58.98	67.95	52.56	65.50
Calculated EPS (Ann.) (Unit Curr.)	263.08	328.40	235.93	271.81	210.23	262.00
Calculated EPS (Adj) (Ann.) (Unit Curr.)	263.08	328.40	235.93	271.81	210.23	262.00
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	42.06	42.06	42.06	42.06	42.06	42.06
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	33.49	35.23	34.08	34.32	32.48	34.80
PBDTM(%)	33.36	35.10	33.93	34.30	32.46	34.79
PATM(%)	23.87	25.67	20.77	22.22	19.79	21.66

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15	Mar 14
SOURCES OF FUNDS :
Share Capital	42.06	42.06	42.06	42.06	42.06	42.06
Reserves Total	4052.66	3443.06	3080.61	2756.65	2070.98	1770.79
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	4094.72	3485.12	3122.67	2798.71	2113.04	1812.85
Secured Loans	0.00	0.00	8.36	12.75	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	8.36	12.75	0.00	0.00
Total Liabilities	4094.72	3485.12	3131.03	2811.46	2113.04	1812.85
APPLICATION OF FUNDS :
Gross Block	696.76	650.85	629.35	569.43	1059.28	854.62
Less : Accumulated Depreciation	234.69	175.32	141.93	88.16	567.54	514.71
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	462.07	475.53	487.42	481.27	491.74	339.91
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	17.73	38.25	57.67	51.39	42.31	38.45
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	465.47	409.42	461.14	461.62	466.25	407.42
Sundry Debtors	385.68	278.72	321.00	354.16	313.36	299.35
Cash and Bank	4097.34	3585.20	3087.38	2712.27	2296.52	1838.78
Loans and Advances	318.94	288.67	269.61	229.55	229.29	208.39
Total Current Assets	5267.42	4562.00	4139.14	3757.60	3305.42	2753.93
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	1481.69	1428.22	1282.48	1140.51	1290.91	1134.78
Provisions	332.29	314.38	304.79	305.47	395.14	296.81
Total Current Liabilities	1813.98	1742.59	1587.27	1445.98	1686.05	1431.59
Net Current Assets	3453.44	2819.41	2551.87	2311.62	1619.37	1322.34
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	142.59	142.08	153.81	127.83	122.43	106.84
Deferred Tax Liability	28.70	26.63	26.01	14.69	18.09	16.54
Net Deferred Tax	113.89	115.45	127.80	113.14	104.34	90.30
Total Assets	4047.13	3448.64	3224.77	2957.42	2257.77	1791.00
Contingent Liabilities	145.61	140.34	135.06	129.79	605.36	393.17

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash and Cash Equivalents at Beginning of the year	614.10	700.91	1061.67	925.38	205.38
Net Cash from Operating Activities	671.07	723.04	602.97	573.46	611.47
Net Cash Used In Investing Activities	-335.06	-446.45	-602.40	-151.58	330.69
Net Cash Used In Financing Activities	-376.80	-363.40	-361.33	-285.59	-222.15
Net Inc./Dec In Cash And Cash Equivalents	-40.78	-86.81	-360.75	136.29	720.00
Cash And Cash Equivalents At End Of The Year	573.32	614.10	700.91	1061.67	925.38

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

72.46%

FII Shareholding

4.58%

DII Shareholding

6.56%

Public Shareholding

16.40%

**Promoter pledged shareholding 72.46%

About GlaxoSmithkline Consumer Healthcare Ltd(Merged)

GlaxoSmithkline Consumer Healthcare Ltd(Merged) is in the FMCG sector, having a market capitalization of Rs. 45229.85 crores. It has reported a sales of Rs. 1158.86 crores and a net profit of Rs. 276.63 crores for the quarter ended December 2018. The company management includes P Dwarakanth, Kunal Kashyap,Naresh Dayal,P Dwarakanth,Sangeeta Talwar,Shanu Saksena,Anup Dhingra,Navneet Saluja,S Madhavan,Pradeep V Bhide (GlaxoSmithkline Consumer Healthcare Ltd(Merged)) among others.

Chairman

P Dwarakanth

Registered office

Patiala Road,,Nabha,Punjab,147201

FAX :91-1765-220642

Background

Incorporation Year1958

Face Value₹10

Market Lot1

How to buy GlaxoSmith C H L shares on nse?

To buy GlaxoSmith C H L shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the GlaxoSmith C H L share price today?

The GlaxoSmith C H L shares price on nse is Rs.10732.6 today.

What is the market cap of GlaxoSmith C H L shares on NSE ?

The company has a market capitalization of Rs.45141.32Cr

What is the PE & PB ratio of GlaxoSmith C H L shares ?

PE is 39.13 and PB is 10.87

What is the 52 Week High and Low of GlaxoSmith C H L shares?

GlaxoSmith C H L stock price high: Rs.10850 GlaxoSmith C H L stock price low: Rs.0